review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Xin Chen | |
Shanshan Zhou | |||
Lanping Zhu | |||
Lingling Gu | |||
Cuirong Liang | |||
P2860 | cites work | Topology and organization of the Salmonella typhimurium type III secretion needle complex components | Q21131560 |
Structural insights into the assembly of the type III secretion needle complex. | Q24547949 | ||
Atomic model of the type III secretion system needle | Q24604172 | ||
Identification and characterization of a novel type III secretion system in trh-positive Vibrio parahaemolyticus strain TH3996 reveal genetic lineage and diversity of pathogenic machinery beyond the species level | Q24644486 | ||
A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system | Q27655277 | ||
Three-dimensional model of Salmonella's needle complex at subnanometer resolution | Q27666889 | ||
Biological weapons--a primer for microbiologists | Q28215581 | ||
Chaperone release and unfolding of substrates in type III secretion | Q28275782 | ||
Protein delivery into eukaryotic cells by type III secretion machines | Q28276443 | ||
Targeting bacterial virulence: inhibitors of type III secretion in Yersinia | Q31137077 | ||
Small molecules aimed at type III secretion systems to inhibit bacterial virulence | Q41974659 | ||
Tethered thiazolidinone dimers as inhibitors of the bacterial type III secretion system. | Q42148231 | ||
Substituted 2-imino-5-arylidenethiazolidin-4-one inhibitors of bacterial type III secretion. | Q43177321 | ||
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II: physico-chemical properties and structure elucidation | Q46575462 | ||
Structure of an OhrR-ohrA operator complex reveals the DNA binding mechanism of the MarR family | Q46739652 | ||
Type III secretion: what's in a name? | Q48704278 | ||
Assembly of the inner rod determines needle length in the type III secretion injectisome | Q50080247 | ||
Derivative of plant phenolic compound inhibits the type III secretion system of Dickeya dadantii via HrpX/HrpY two-component signal transduction and Rsm systems. | Q54286218 | ||
A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. | Q54374354 | ||
Caminoside A, an antimicrobial glycolipid isolated from the marine sponge Caminus sphaeroconia | Q78492240 | ||
Caminosides B-D, antimicrobial glycolipids isolated from the marine sponge Caminus sphaeroconia | Q82653366 | ||
Fire Blight Management in the Twenty-first Century: Using New Technologies that Enhance Host Resistance in Apple | Q91974492 | ||
Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. | Q33224085 | ||
An inhibitor of gram-negative bacterial virulence protein secretion | Q33375894 | ||
Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion | Q33533545 | ||
Small Molecule Inhibitors of LcrF, a Yersinia pseudotuberculosis Transcription Factor, Attenuate Virulence and Limit Infection in a Murine Pneumonia Model | Q33686625 | ||
Small-molecule inhibitors specifically targeting type III secretion | Q33768953 | ||
Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection | Q33836925 | ||
Derivatives of plant phenolic compound affect the type III secretion system of Pseudomonas aeruginosa via a GacS-GacA two-component signal transduction system | Q34039055 | ||
Salmonella interactions with host cells: type III secretion at work | Q34425135 | ||
Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties | Q34592395 | ||
Antibiotic use in plant agriculture | Q34766474 | ||
Discovery of plant phenolic compounds that act as type III secretion system inhibitors or inducers of the fire blight pathogen, Erwinia amylovora. | Q34774479 | ||
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis | Q35029284 | ||
Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues | Q35165118 | ||
Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system | Q35178637 | ||
Temperature sensing in Yersinia pestis: regulation of yopE transcription by lcrF | Q36113530 | ||
The bacterial injection kit: type III secretion systems | Q36194906 | ||
The biology and future prospects of antivirulence therapies | Q36397902 | ||
Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice | Q36401192 | ||
Regulation of virulence by members of the MarR/SlyA family | Q36418301 | ||
New structural insights into the bacterial type III secretion system | Q36421215 | ||
Regulation of the type III secretion system in phytopathogenic bacteria. | Q36638321 | ||
Type III secretion systems and disease | Q36969851 | ||
Structure and biophysics of type III secretion in bacteria | Q37014297 | ||
The plant phenolic compound p-coumaric acid represses gene expression in the Dickeya dadantii type III secretion system. | Q37110443 | ||
Antivirulence as a new antibacterial approach for chemotherapy | Q37221247 | ||
N-hydroxybenzimidazole inhibitors of the transcription factor LcrF in Yersinia: novel antivirulence agents | Q37423363 | ||
Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung | Q37624028 | ||
Anti-virulence strategies to combat bacteria-mediated disease | Q37676924 | ||
The type III secretion injectisome, a complex nanomachine for intracellular 'toxin' delivery | Q37756149 | ||
Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria | Q37857710 | ||
Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors | Q37859785 | ||
Biogenesis, regulation, and targeting of the type III secretion system | Q37874812 | ||
Enteropathogenic Escherichia coli infection induces expression of the early growth response factor by activating mitogen-activated protein kinase cascades in epithelial cells. | Q39522387 | ||
Supramolecular structure of the Shigella type III secretion machinery: the needle part is changeable in length and essential for delivery of effectors | Q40392389 | ||
The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells | Q41390851 | ||
SycE allows secretion of YopE-DHFR hybrids by the Yersinia enterocolitica type III Ysc system. | Q41470047 | ||
Modulation of virulence factor expression by pathogen target cell contact | Q41490662 | ||
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibiotic | Q12187 |
macromolecular substance | Q75174158 | ||
P304 | page(s) | 17659-17674 | |
P577 | publication date | 2015-09-23 | |
P1433 | published in | Molecules | Q151332 |
P1476 | title | Small-Molecule Inhibitors of the Type III Secretion System | |
P478 | volume | 20 |
Q41006822 | A dynamic and adaptive network of cytosolic interactions governs protein export by the T3SS injectisome |
Q26751034 | Bacterial Control of Pores Induced by the Type III Secretion System: Mind the Gap |
Q40116893 | Characterization of Small-Molecule Scaffolds That Bind to the Shigella Type III Secretion System Protein IpaD. |
Q89602486 | Exploring resveratrol dimers as virulence blocking agents - Attenuation of type III secretion in Yersinia pseudotuberculosis and Pseudomonas aeruginosa |
Q60949639 | High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors |
Q40298917 | In Situ Molecular Architecture of the Salmonella Type III Secretion Machine |
Q88011724 | Protein-Injection Machines in Bacteria |
Q57114106 | Small Molecule Inhibitor of Type Three Secretion System Belonging to a Class 2,4-disubstituted-4H-[1,3,4]-thiadiazine-5-ones Improves Survival and Decreases Bacterial Loads in an Airway Infection in Mice |
Q92557925 | Tanshinones: First-in-Class Inhibitors of the Biogenesis of the Type 3 Secretion System Needle of Pseudomonas aeruginosa for Antibiotic Therapy |
Q55002237 | The Herbal Compound Thymol Protects Mice From Lethal Infection by Salmonella Typhimurium. |
Q40182759 | The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo |
Q48114171 | Visualization and characterization of individual type III protein secretion machines in live bacteria |
Search more.